Cell & Gene Therapy Drug Delivery Market
Cell & Gene Therapy Drug Delivery Market: Key Finding, Latest Industry Trends, Growth Status, Revenue and Forecast to 2028
According to MarkNtel Advisors who is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. Recently released a report on Cell & Gene Therapy Drug Delivery Market - Industry Trends and Forecast to 2028 and provides a comprehensive analysis of the current and future market conditions. The market research insights offered in this report enhance understanding of the market landscape, potential challenges, and strategies to establish a strong brand presence. With detailed market segmentation, in-depth analysis of key players, examination of consumer and supply chain trends, and exploration of new geographic markets, the insights presented in this report simplify the effective marketing of products and services.
Global Cell & Gene Therapy Drug Delivery Market Analysis and Size
The Global Cell & Gene Therapy Drug Delivery Devices Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28, says MarkNtel Advisors.
“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”
Get a Free Sample PDF Copy of this Report to understand structure of the complete report @ https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html
Some of the major players operating in the Cell & Gene Therapy Drug Delivery Market are Amgen Inc., Bausch & Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio Inc., Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.), Dendreon Pharmaceuticals LLC, Helixmith Co. Ltd (ViroMed Co., Ltd), Human Stem Cells Institute, Kite Pharma Inc., Kolon TissueGene, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer Inc., Renova Therapeutics, Spark Therapeutics Inc., uniQure N.V., Vericel Corporation.
Cell & Gene Therapy Drug Delivery Market Growth Driver:
The factors that are projected to drive the market in the coming years include the following:
Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
Mounting prevalence of genetic disorders & chronic diseases
An increasing number of FDA approvals for cell & gene therapies & their clinical trials
Browse More About This Research Report @ https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html
Market Segment and Geographical Analysis
By Product Type
Sub-retinal Injection Cannula
Extension Tube
Intravenous Catheter
Sterile Insulin Syringe
Size 1.0 ML, 31-Gauge Needle
Size 0.5 ML, 22-Gauge Needle
Pre-Filled Syringe
Size 1.0 ML, 22-26 Gauge Needle
Size 4.0 ML, 22-26 Gauge Needle
Infusion Bags
Infusion Bags (Size 10 ML to 50 ML)
Infusion Bags (Size 68 ML)
Infusion Bags (Size 60 ML)
Infusion Bags (Size Up to 65 ML)
By Technology
Microchip Technology
Nano-Technology
Lipid Nanoparticles
By Commercialized Drugs
Luxturna
Kymriah
Yescarta
Zolgensma
Provenge
Strimvelis
By End-User
Pharmaceuticals & Biotechnology Company
Academic & Research Institute
Hospitals & Clinics
By Region
North America
South America
Europe
Middle East & Africa
Asia-Pacific
Note - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Trending Reports:
Note: If you require specific information not covered in the current report, we can provide it through customized option
Why choose Us?
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India